Home Companies Merck & Co pens $340m pain drug deal with KCL and Wellcome

Merck & Co pens $340m pain drug deal with KCL and Wellcome

by admin
0 comment
Merck , KCL and Wellcome


Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers that could provide an alternative to opioids and their dangerous side-effects.

Known as MSD outside of the US, the big pharma has signed a collaborative licence deal with KCL to investigate a class of drugs that blocks a protein known as HCN2, which has been shown to play a role in chronic pain.

Merck , KCL and Wellcome

Merck deal with KCL and Wellcome

HCN2 can cause a continuous sensation of pain when electrical signals are passed through pain-sensitive nerve fibre.

Research conducted at KCL shows that blocking activity of HCN2 in animal models can deliver effective pain relief without side effects.

The deal is made possible through the work of Professor Peter McNaughton from the Institute of Psychiatry, Psychology and Neuroscience at King’s.

King’s IP and Licensing team and the Wellcome’s Innovations team have negotiated a deal with Merck where they are eligible to receive up to $340 million (£263 million) in development and sales milestones, as well as royalties if a drug comes to market.

MSD will also fund further research at McNaughton’s lab into the biological mechanisms of pain.

For more Information: Sign in Websites for Agrochemical & Pharmaceutical Databases:

Website : https://www.chemrobotics.com/ (Agrochemical Databases)

Website : https://chemroboticspharma.com/  (Pharmaceutical Databases)

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Our Company

ChemRobotics is a global Scientific, Technical & Business data intelligence company, especially in the field of Pharmaceutical, Agrochemical, Veterinary and Fine Chemical.

ChemRobotics Times

Subscribe ChemRobotics for the latest updates in the Pharmaceutical, Agrochemical, Veterinary, and Fine Chemical Industries

Laest News

ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved. 

Designed and Developed by Ample eBusiness